Huntington National Bank’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.17K Buy
2,481
+2,480
+248,000% +$3.61K ﹤0.01% 2291
2026
Q1
$1 Hold
1
﹤0.01% 4083
2025
Q4
$2 Hold
1
﹤0.01% 3936
2025
Q3
$1 Hold
1
﹤0.01% 4017
2025
Q2
$1 Hold
1
﹤0.01% 4024
2025
Q1
$1 Hold
1
﹤0.01% 4038
2024
Q4
$2 Hold
1
﹤0.01% 3984
2024
Q3
$2 Hold
1
﹤0.01% 3977
2024
Q2
$1 Hold
1
﹤0.01% 3975
2024
Q1
$4 Hold
1
﹤0.01% 3735
2023
Q4
$10 Hold
1
﹤0.01% 3454
2023
Q3
$8 Hold
1
﹤0.01% 3483
2023
Q2
$13 Hold
1
﹤0.01% 3311
2023
Q1
$12 Hold
1
﹤0.01% 3180
2022
Q4
$8 Hold
1
﹤0.01% 3161
2022
Q3
$0 Hold
1
﹤0.01% 2291
2022
Q2
$0 Hold
1
﹤0.01% 2314
2022
Q1
$0 Hold
1
﹤0.01% 2274
2021
Q4
$0 Hold
1
﹤0.01% 2228
2021
Q3
$0 Hold
1
﹤0.01% 1970
2021
Q2
$0 Hold
1
﹤0.01% 1885
2021
Q1
$0 Hold
1
﹤0.01% 1773
2020
Q4
$0 Hold
1
﹤0.01% 1738
2020
Q3
$0 Hold
1
﹤0.01% 1692
2020
Q2
$0 Hold
1
﹤0.01% 1689
2020
Q1
$0 Hold
1
﹤0.01% 1759
2019
Q4
$0 Hold
1
﹤0.01% 1826
2019
Q3
$0 Hold
1
﹤0.01% 1704
2019
Q2
$0 Buy
+1
New +$7 ﹤0.01% 1747
2019
Q1
Sell
-1
Closed 1729
2018
Q4
$0 Hold
1
﹤0.01% 1810
2018
Q3
$0 Buy
+1
New +$4 ﹤0.01% 1828

Other funds holding PACB

Huntington National Bank's PACB Position: Q2 2026 in Review

Huntington National Bank increased its Pacific Biosciences (PACB) stake by 248,000% in Q2 2026, buying an estimated $3.61K and bringing the position to 2,481 shares worth $4.17K. The position accounts for ﹤0.01% of the portfolio, ranked #2291.

Huntington National Bank first reported a position in PACB in Q3 2018 and has held it in 31 quarters since. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Huntington National Bank held 2,481 shares of Pacific Biosciences worth $4.17K as of Q2 2026.
  • Huntington National Bank bought 2,480 Pacific Biosciences shares in Q2 2026, an estimated $3.61K.
  • Pacific Biosciences made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #2291 holding.
  • Huntington National Bank first reported a position in Pacific Biosciences in Q3 2018 and has held it in 31 quarters since.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.